|
Introduction to Multikine®
Multikine® is a new type of immunotherapy. It is combination immunotherapy (i.e., it has both active and passive immune activity).
Combination immunotherapy most closely resembles the workings of the natural immune system in the sense that it works on multiple fronts in the battle against cancer.
Combination immunotherapy:
| |
• |
Causes a direct and targeted killing of the tumor cells and |
|
| |
|
|
|
| |
• |
Activates the immune system to produce a more robust and sustainable anti-tumor response. |
|
Multikine® is comprised of a mixture of cytokines; it is not one cell or one protein; it is a combination of molecules and proteins that act like the immune system.
| |
• |
Multikine® is a patented defined mixture of biologically active, natural cytokines that simulate the body’s healthy immune response. The cytokine mixture includes interleukins, interferons, chemokines, and colony-stimulating factors. |
|
| |
|
|
|
| |
• |
Cytokines play a key role in regulating the body’s immune system. |
|
| |
|
|
|
| |
• |
Multikine® is not an autologous therapy, (derived from and customized for the patient). It is a ready-to-use, mass produced, off-the-shelf therapy. |
|
| |
|
|
|
| |
• |
Multikine® has been shown to be safe and well tolerated and is non-toxic to healthy cells. |
|
|
